NuSirt Biopharma launching new clinical trial

NuSirt BiopharmaNuSirt Biopharma, a company founded by Michael Zemel in Knoxville several years ago, has announced plans to launch a clinical trial to determine if its patented technology is a potential treatment for non-alcoholic fatty liver disease and steatohepatitis. The start-up, now based in Nashville, still maintains its research facilities here. For more information about the trial plans, read the news release. For our three-part series on the company, here are the links: Part 1, Part 2, and Part 3.

Stay connected with us on Twitter and LinkedIn. Article ideas and other suggestions should be sent to Include the name and contact information (phone and email) for follow-up.